In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer - Wikidata - awgldk - TriplyDB

In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer

In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer

http://www.wikidata.org/entity/Q34667419

about

Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway Targeting tumor suppressor networks for cancer therapeutics.Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death.A Comparative Study of Mouse Hepatic and Intestinal Gene Expression Profiles under PPARα Knockout by Gene Set Enrichment Analysis The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genes Retinoic acid inhibits endometrial cancer cell growth via multiple genomic mechanisms Expression Profiling Identifies Bezafibrate as Potential Therapeutic Drug for Lung Adenocarcinoma.PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.PPARα modulates gene expression profiles of mitochondrial energy metabolism in oral tumorigenesis Peroxisome proliferator activated receptor α ligands as anticancer drugs targeting mitochondrial metabolism Fenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer.PPAR Ligands for Cancer Chemoprevention.Synergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis.Role of peroxisome proliferator-activated receptor alpha in the control of cyclooxygenase 2 and vascular endothelial growth factor: involvement in tumor growth.PPARalpha Ligands as Antitumorigenic and Antiangiogenic Agents Stimulating effect of normal-dosing of fibrates on cell proliferation: word of warning.The Role of PPARs in the Endothelium: Implications for Cancer Therapy Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.PPARα, a predictor of patient survival in glioma, inhibits cell growth through the E2F1/miR-19a feedback loop.A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-kappaB signaling axis.Peroxisome Proliferator-Activated Receptor Ligands and Their Role in Chronic Myeloid Leukemia: Therapeutic Strategies.Fenofibrate induces G0/G1 phase arrest by modulating the PPARα/FoxO1/p27 kip pathway in human glioblastoma cells.Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells.Regulation of URG4/URGCP and PPARα gene expressions after retinoic acid treatment in neuroblastoma cells.Novel MEK inhibitor trametinib and other retinoblastoma gene (RB)-reactivating agents enhance efficacy of 5-fluorouracil on human colon cancer cells.Differential Effects of MicroRNAs on Glioblastoma Growth and Migration.Metabolic Reprogramming in Glioma.Fenofibrate-induced nuclear translocation of FoxO3A triggers Bim-mediated apoptosis in glioblastoma cells in vitro.Generation and characterization of orthotopic murine models for endometrial cancer.ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro.Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells.Fenofibrate: direct attenuating effects on tumor growth RA and ω-3 PUFA co-treatment activates autophagy in cancer cells.Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells.Anticancer Properties of Fenofibrate: A Repurposing Use.

P2860

Q28385524-0D213E5D-09DC-431B-9ECD-70F9EF90BDAA Q33589182-5BF8FAF8-B9DC-4B58-9BFF-B8422D708FD9 Q33657519-A5046B9E-C31C-4C2F-9C30-241DB33A9C35 Q34968487-77EC503E-517E-49BA-A94E-F9BE00B18A9C Q35138153-A598891F-2079-4EA9-8123-BA3356133CDB Q35677612-B5529A6D-697B-4DDD-B1A5-A89E6F863466 Q35880096-9A125934-65C6-498B-8CD1-3BDA8DE53DEF Q36214115-7F3EAA0E-33BD-42DD-8578-53C3D9AE7494 Q36458927-84472321-D9E2-48C2-B0E7-2F165B6AF4E0 Q36573120-DA30BAE8-F893-48D4-A470-D1D7D22CD625 Q36781253-C06CA2F2-836F-4A9B-B973-4F11E17B4AC2 Q37012110-EEF8EEB5-2903-4F42-BB38-0D137ED85FA9 Q37165190-06AC84FA-9730-4BF5-8BB6-FEF2C7666ECF Q37182802-4E7714CB-8B46-48CA-A675-ED7C39F20696 Q37190455-B411473A-E43A-4A81-A75E-EC3A8CD64091 Q37231752-933C1AAC-86BA-4847-81B0-84AF3EDE5EC8 Q37251719-16A3AF02-1A32-4EFA-B024-F925FB309032 Q37278876-497C2DC3-2468-4805-999B-84B04FDBA036 Q37337997-7CCD2F3E-C928-46E9-90DE-3B4109D00942 Q37565240-CDA005AF-4672-4BF5-87FE-64DB9DC341BD Q37708993-45A91DE0-643A-4D73-9A10-391D5B99CD78 Q37739218-003ED300-F231-4801-AB60-83897D31B613 Q38343572-11CC46E4-C6CF-48CE-8632-E168AF7BC648 Q38721726-16DA533F-76D7-4406-83B7-E4733B16A85F Q38922376-DAB85647-C22C-4B9C-835E-4F8B97890A35 Q38941022-5D5E7EF3-84FB-43F8-8AF2-525BA57304A1 Q39131301-AC1DE9FD-9986-4752-B8D0-93CF789DFB4E Q39189050-DB3ED106-C318-46E8-A6B5-38B5D3A0C7FE Q39219681-3463488C-09D1-4B65-B99C-3BFF20E576DE Q39297355-6A0CDFEA-A699-4DCF-BFD4-14171F33009D Q39325469-8A7E3153-B4AD-470A-81E8-47CB0A5C0FEC Q39422372-57D74882-623E-4E2A-9EE1-9538E937BE3C Q39689666-70320050-DCB7-46E9-8AA8-B9D573EB3280 Q40008527-3C27D3F0-5DF3-4562-AD68-28174F57D44D Q40011181-F64021C6-115F-49B7-915E-5481EA2B56D2 Q47192015-A3F24D10-E960-4D26-AFB6-5FEEFFE372BD Q47405898-40E1FAED-2D4B-4B3B-AC13-16E74FE0A3EE Q55021652-B1DB67A0-C5CD-4172-917D-9637BF538E87

P2860

In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer

http://www.wikidata.org/entity/Q34667419

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

In vitro and in vivo effects o ...... oic acid in endometrial cancer

@ast

In vitro and in vivo effects o ...... oic acid in endometrial cancer

@en

In vitro and in vivo effects o ...... oic acid in endometrial cancer

@nl

type

label

In vitro and in vivo effects o ...... oic acid in endometrial cancer

@ast

In vitro and in vivo effects o ...... oic acid in endometrial cancer

@en

In vitro and in vivo effects o ...... oic acid in endometrial cancer

@nl

prefLabel

In vitro and in vivo effects o ...... oic acid in endometrial cancer

@ast

In vitro and in vivo effects o ...... oic acid in endometrial cancer

@en

In vitro and in vivo effects o ...... oic acid in endometrial cancer

@nl

P1433

Q34667419-8C24C636-B035-461C-A5B1-56C103354B40

P1476

Q34667419-6158E44B-4A69-42C0-AA94-5F002345D891

P2093

Q34667419-3EC04759-2873-4CD8-893F-23EBB5831923

Q34667419-DAE5E1BE-78B4-409C-B87C-E2F9621B84B4

P2860

Q34667419-04618523-B824-47D1-AECE-09522B227D92

Q34667419-06217153-FF0A-49D0-9485-76E04D871A35

Q34667419-0967DF5A-5DC7-419F-8C14-E6C210E8BC5A

Q34667419-09EE5857-CB0D-42E3-9C75-ECC16DC0C995

Q34667419-0D7267F2-47AE-4083-857D-F30769740F65

Q34667419-0F0EACF1-83A8-4CA9-800A-3186D15FA612

Q34667419-11628359-4E3F-41DC-A47C-CF3BA595D834

Q34667419-1585EB91-F96D-43C1-946D-97AB5DD1BBAE

Q34667419-1B26FC0A-DABC-4F15-86E9-4EDDD9C19148

Q34667419-2B8AC326-3D17-4E07-A616-71147E57BF99

P2888

Q34667419-0C978029-9CE8-4612-8342-70A3A0CDA32F

P304

Q34667419-53DD9052-DD98-480B-B44F-38BC45176A69

P31

Q34667419-6B116874-ABDA-4338-826A-C0CFAEDAE125

P356

Q34667419-1EEB6F90-C764-4DA2-84BB-26A753CC7F1D

P478

Q34667419-060AD696-69F9-4BCB-BDAC-EF154EF83BCB

P50

Q34667419-BBF8CF5C-392D-4C0C-80B4-8F83BECF029D

Q34667419-CDE786D3-8AE9-4A50-A09F-B2CF7A10DA43

P577

Q34667419-5DA1BA58-F01F-48D0-8827-8FB9AD9B6080

P5875

Q34667419-D81AFDE8-9475-43C3-957F-F9E9B273BA56

P6179

Q34667419-66659CC5-FB41-42DF-B530-57E83E191B91

P698

Q34667419-4A198AA6-9844-4BD7-94CF-D1D87282CCC6

P921

Q34667419-F707E810-3467-49C8-85AC-9CAC1D0D43CD

P932

Q34667419-21368848-7453-41B1-B825-FD73D74DB71C

P356

P1433

Molecular Cancer

P1476

In vitro and in vivo effects o ...... oic acid in endometrial cancer

@en

P2093

Cathrine M Holland

http://www.w3.org/2001/XMLSchema#string

Samir A Saidi

http://www.w3.org/2001/XMLSchema#string

P2860

Gene ontology: tool for the unification of biology

Significance analysis of microarrays applied to the ionizing radiation response

RNA interference

Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-beta connection

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

Cancer cell cycles

A molecular signature of metastasis in primary solid tumors

A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes

PPARs and the complex journey to obesity

P2888

P304

13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-4598-5-13

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Stephen K. Smith

D. Stephen Charnock-Jones

P577

2006-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7210571

http://www.w3.org/2001/XMLSchema#string

P6179

1003569292

http://www.w3.org/2001/XMLSchema#string

P698

16569247

http://www.w3.org/2001/XMLSchema#string

P921

P932

1475879

http://www.w3.org/2001/XMLSchema#string